219 related articles for article (PubMed ID: 30396479)
1. Oral manifestations in stem cell transplantation for acute myeloid leukemia.
Mester A; Irimie A; Oprita L; Dima D; Petrushev B; Lucaciu O; Campian RS; Tanase A
Med Hypotheses; 2018 Dec; 121():191-194. PubMed ID: 30396479
[TBL] [Abstract][Full Text] [Related]
2. Oral complications of bone marrow transplantation in adults with acute leukemia.
Dreizen S; McCredie KB; Dicke KA; Zander AR; Peters LJ
Postgrad Med; 1979 Nov; 66(5):187-93, 196. PubMed ID: 40210
[TBL] [Abstract][Full Text] [Related]
3. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen.
Gürgan CA; Özcan M; Karakuş Ö; Zincircioğlu G; Arat M; Soydan E; Topcuoglu P; Gürman G; Bostancı HS
Int J Dent Hyg; 2013 May; 11(2):84-90. PubMed ID: 22487659
[TBL] [Abstract][Full Text] [Related]
4. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
[No Abstract] [Full Text] [Related]
5. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
[TBL] [Abstract][Full Text] [Related]
6. Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation.
Wysocka-Słowik A; Gil L; Ślebioda Z; Dorocka-Bobkowska B
Med Oral Patol Oral Cir Bucal; 2021 Sep; 26(5):e642-e650. PubMed ID: 34162819
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS.
Dahi PB; Morawa E; Perales MA; Zabor EC; Devlin SM; Maloy M; Castro-Malaspina H; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Giralt SA
Bone Marrow Transplant; 2016 Jul; 51(7):991-3. PubMed ID: 26926229
[No Abstract] [Full Text] [Related]
8. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
[No Abstract] [Full Text] [Related]
9. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.
Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A
J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
11. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
12. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune polyglandular syndrome type III after haploidentical hematopoietic stem cell transplantation in a child with acute myeloid leukemia.
Kleinschmidt K; Martoni A; Masetti R; Cassio A; Prete A; Pession A
Pediatr Blood Cancer; 2012 Aug; 59(2):341. PubMed ID: 21994118
[No Abstract] [Full Text] [Related]
15. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
16. Multiple cutaneous reticulohistiocytomas after haematopoietic cell transplantation: contribution of donor- and host-derived cells.
Kosumi H; Natsuga K; Watanabe M; Okada K; Shimizu H
Br J Dermatol; 2019 Mar; 180(3):680-681. PubMed ID: 30411317
[No Abstract] [Full Text] [Related]
17. Oral condition of patients with leukemia and lymphoma.
Orbak R; Orbak Z
J Nihon Univ Sch Dent; 1997 Jun; 39(2):67-70. PubMed ID: 9293702
[TBL] [Abstract][Full Text] [Related]
18. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
20. Severe gingival recession and early loss of teeth in a child with chronic graft versus host disease: a case report.
da Fonseca MA; Murdoch-Kinch CA
Spec Care Dentist; 2007; 27(2):59-63. PubMed ID: 17539221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
